Type I Achalasia

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Type I Achalasia trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT01793168

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, i…

United States, Australia20,000 participantsStarted 2010-07

All recent trials (3 shown)

Not Yet RecruitingPhase 3

NCT07293650

PREcision MEDicine In Achalasia (PREMEDIA)

The goal of this clinical trial is to learn if shorter Per-Oral Endoscopic Myotomy (POEM) works as well as a longer POEM in patients with trouble swallowing due…

United States372 participantsStarted 2026-04-01

Treatment: Standard Myotomy, Tailored Short Myotomy

TerminatedPhase 2

NCT02931565

Study of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Type I or II Achalasia

The objectives of this study are as follows: In participants with primary Type I or II achalasia, following a single 5-mg dose of olinciguat (IW-1701), * To a…

United States9 participantsStarted 2017-04-06

Treatment: Olinciguat, Matching Placebo